+86-2988253271

What Exactly Is Bulk Ursodeoxycholic Acid?

Oct 19, 2023

Guanjie focuses on bulk ursodeoxycholic acid producing and trading. Ursodeoxycholic acid is also called UDCA. But what is  ursodeoxycholic acid? UDCA chemically known as 3a,7β-dihydroxy-5β-cholestan-24-oic acid. It is an organic compound that is odorless and has a bitter taste. It is used medically to increase bile acid secretion and to cause changes in bile composition. This reduces cholesterol and cholesterol lipids in bile and facilitates the gradual dissolution of cholesterol in gallstones.

ursodeoxycholic acid

What Are The Pharmacological Actions of Ursodeoxycholic Acid?

1. Hepatoprotective effect

The cytoprotective effects of UDCA are mainly beneficial to hepatocytes and bile duct cells:

• UDCA is a hydrophilic bile acid. Thus, it helps to protect phospholipid-rich cell membranes from damage by hydrophobic bile acids such as CDCA.

 

• Hydrophobic bile acids, such as CDCA, can cause apoptosis resulting in severe liver tissue damage. Eventually, liver cirrhosis develops. UDCA can inhibit the apoptotic process of bile duct epithelial cells and liver parenchymal cells induced by toxic bile acids, thus inhibiting the pathological process of cirrhosis.

 

• UDCA can competitively replace toxic bile acid molecules on cell membranes and organelles. It prevents the direct damage of toxic bile acids to hepatocytes.

 

• Bulk ursodeoxycholic acid competitively inhibits ileal absorption of endogenous hydrophobic bile acids. Makes UDCA the major bile acid in serum and bile. Inhibits hydrophobic bile acid-induced apoptosis and necrosis of hepatocytes.

 

2. Choleretic effect

UDCA has a choleretic effect. It can promote the secretion of hydrophobic bile acids from bile duct cells. UDCA can reduce the level of CDCA in serum, reduce the accumulation of bile acids, and increase the secretion ability of hepatocytes that have originally accumulated bile.UDCA can also increase the secretion of phospholipids from bile, and UDCA has a protective effect on hepatocytes.UDCA can promote the conversion of cholesterol to bile acids, increase the excretion of cholesterol, and prevent the formation of gallstones.

UDCA powder

3. Immune regulation

Cholestasis has a correlation with the immune system. In cholestasis, the main mechanism of bile duct damage is T cell-mediated cytotoxic damage and apoptosis. The major histocompatibility complex (MHC)-I and MHC-II antigens are also abnormally expressed in the bile duct epithelium, further exacerbating the autoimmune damage to the bile ducts.UDCA inhibits the expression of human leukocyte antigens (HLAs) in the bile duct epithelium, which promotes the restoration of the natural killing ability of lymphocytes in patients with primary biliary cholangitis (PBC). UDCA treatment resulted in a significant reduction in the aberrant expression of .MHC molecules by hepatocytes, which reduced cytotoxic T-cell (CTL) damage to their own tissues.

 

On Ursodeoxycholic Acid (UDCA) for the Prevention and Treatment of Neocoronaviruses

● Mechanism of action

Specifically, farnesol X receptor (FXR) is a direct regulator of ACE2 transcription. Ursodeoxycholic acid is able to down-regulate ACE2 expression by inhibiting FXR, thereby shutting down the neocoronavirus's access to ACE2 into human cells, because the drug acts on the host cell, not the virus itself. So the drug should be able to prevent not only current neocoronavirus infections, but also future new mutants of neocoronavirus, as well as other coronaviruses that utilize ACE2. The research team says that if this is further confirmed in subsequent larger clinical trials. would provide a crucial drug to protect those for whom the vaccine is ineffective or who cannot be vaccinated.

 

Vaccines protect by boosting the immune system to recognize and clear the virus, the researchers said. But vaccines don't work for everyone, such as some people with weakened immune systems. Vaccines are also not suitable for everyone. In addition, viruses are constantly mutating, causing vaccines to be less protective. And this study has discovered a way to close the door for new coronaviruses to enter the body's cells, stopping the virus from invading in the first place and protecting the body from infection.

 

● Animal experiments

The research team further demonstrated that ursodeoxycholic acid can prevent neocoronavirus infection in cultured cells in vitro. It was also effective in preventing infection in hamsters exposed to neocoronavirus. The hamster is the "gold standard" model for preclinical studies of anticoronaviral drugs. These data provide compelling evidence to supplement vaccination. It is suggested that ursodeoxycholic acid could be used as a drug to prevent neocoronavirus infections.

 

● Human organ research

The research team again chose human donor lungs unsuitable for transplantation and kept the lungs breathing outside the body by means of a ventilator. And a pump was used to keep them circulating inside the body to maintain organ function while research was conducted. They injected bulk ursodeoxycholic acid into one lobe of the lung. The entire lung was then exposed to the new coronavirus. The results showed that the lung injected with the drug was not infected, while the other lobe of the lung was infected with the neocoronavirus.

 

● Clinical studies

They conducted an experiment in human volunteers, where eight healthy volunteers were treated with ursodeoxycholic acid drug. The results showed that the treated volunteers had reduced levels of ACE2 in their nasal cells. This greatly reduced the likelihood of the new coronavirus invading and infecting them. In addition, the research team compared patients who were treated with ursodeoxycholic acid medication or not treated with the drug because of liver disease. The results showed that patients treated with the drug were less likely to develop severe neocollins or be hospitalized.

 

● The researchers said

Bulk Ursodeoxycholic acid may be an affordable and effective modality for the general public. It could protect people whose vaccines are ineffective or who are unable to get vaccinated. Ursodeoxycholic acid has been in clinical use for many years and is safe and well tolerated. As it can be produced quickly, in large quantities and at low cost. The drug is also easy to store and transport at room temperature, enabling rapid deployment in the event of an outbreak. In particular, the drug also protects against new mutant strains of Neocoronavirus that may emerge in the future. It could become an important weapon in our fight against a neocoronavirus pandemic.

 

Guanjie is a bulk UDCA supplier. We have our own factory and independent production line. We specialize in customized products. To request a free sample, please contact our experts at info@gybiotech.com.

 

Send Inquiry